Refractory Pituitary Granulomatosis with Polyangiitis (Wegener's) Treated with Rituximab - Endocrine Practice
Frontiers | Evolving Antibody Therapies for the Treatment of Type 1 Diabetes
Safety and efficacy of rituximab in systemic sclerosis (DESIRES): open-label extension of a double-blind, investigators-initiated, randomised, placebo-controlled trial - The Lancet Rheumatology
JCI Insight - Cell type–specific immune phenotypes predict loss of insulin secretion in new-onset type 1 diabetes
Rituximab - Wikipedia
Efficacy of rituximab in difficult-to-manage autoimmune hepatitis: Results from the International Autoimmune Hepatitis Group - ScienceDirect
Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function | NEJM
Ibrutinib–rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial - The Lancet Oncology
![PDF] Immune Interventions to Preserve Beta Cell Function in Type 1 Diabetes | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d152545eac07d3a073b27760de34a2ebe1da5823/14-Figure1-1.png "PDF] Immune Interventions to Preserve Beta Cell Function in Type 1 Diabetes | Semantic Scholar")
PDF] Immune Interventions to Preserve Beta Cell Function in Type 1 Diabetes | Semantic Scholar
JCI - B cell depletion: a novel therapy for autoimmune diabetes?
Autoimmunerkrankungen des ZNS: B-Zelldepletion mit Rituximab beugt Rückfällen der Neuromyelitis optica vor
Rituximab zum Schutz der Betazellen | PZ – Pharmazeutische Zeitung
PV | RITUXAN® (rituximab) Safety Data
PDF) Rituximab Selectively Suppresses Specific Islet Antibodies
Immune Mechanisms and Pathways Targeted in Type 1 Diabetes | SpringerLink
IJMS | Free Full-Text | Therapeutic Advances in Diabetes, Autoimmune, and Neurological Diseases
B cells in type 1 diabetes mellitus and diabetic kidney disease | Nature Reviews Nephrology
Rituximab Treatment Modulates the Release of Hydrogen Peroxide and the Production of Proinflammatory Cytokines by Monocyte at the Onset of Type 1 Diabetes | Bentham Science
Case Report: Faustdick hinter den Ohren - DocCheck
Rituximab helps overcome adverse effects of diabetes mellitus for patients with diffuse large B-cell lymphoma. - Lymphoma Canada
Rituximab – Aktueller Stand – Ein Überblick — Deutsche Gesellschaft für ME/CFS
Immunsuppressivum Rituximab erhöht Sterberisiko bei COVID-19 deutlich
Warum Rituximab bei manchen Patienten mit CLL und anderen Lymphomen nicht so gut wirkt
B-Lymphocyte Depletion With Rituximab and β-Cell Function: Two-Year Results
Linagliptin Diabetes Medikament Molekül (dipeptidyll peptidase 4 oder DPP4-Hemmer). Skelettmuskulatur Formel Stock-Vektorgrafik - Alamy
Diabetes und rheumatische Erkrankungen in der Covid-19-Pandemie | Gelbe Liste
